Human Papillomavirus (HPV) type 16 is the most frequently detected HPV in cervical cancer. Although epidemiologic and experimental evidence indicates a prominent role for HPV infection in the development of this disease, other factors are also involved. Altered expression of the ets family transcription factors erg and ets-2 was found associated with the development of cervical carcinoma. Overexpression also occurred in a HPV-16-immortalized cervical cell line, CX16-2, which has HPV integrated at a translocation breakpoint t(19;21) involving 21q22.2-22.3, where these genes have been mapped. Six of 10 cervical carcinoma cell lines overexpressed ets-2 RNA suggesting an association of overexpression with cervical cell neoplasia. A clonally related pair of cervical carcinoma cell lines, C-4I and C-4II, showed dierential expression of erg and ets-2. C-4I overexpressed ets-2 RNA compared to normal cervical cells and C-4II. C-4II expressed a 5.3 kb erg transcript not seen in C-4I, ectocervical cells or other cervical carcinoma cell lines examined. Pulsed ®eld gel electrophoresis was used to analyse changes in DNA fragments related to structural changes and to construct a physical map encompassing erg and ets-2. Alterations in erg and ets-2 RNA expression in each of three dierent cell lines examined were associated with translocations. Association between altered expression of erg and ets-2 and altered regional structural suggests that these genes are important targets in cervical carcinogenesis.
Introduction
The ets related family of transcription factors are emerging as important targets in neoplasia (reviewed in Seth et al., 1992; Wasylyk et al., 1993) . At least three ets genes form fusion proteins with RNA binding proteins in Ewing's sarcoma (Zucman et al., 1993; Jeon et al., 1995) . One of these genes, erg, is involved in translocations producing similar fusion proteins in human myeloid leukemia (Shimizu et al., 1993) and its expression is associated with stromal cell-independent growth in some murine erythroleukemia cell lines (Nibbs et al., 1993) . Other translocations resulting in fusion proteins involving other members of the ets family have also been described (Buijs et al., 1995; Golub et al., 1995) . A highly homologous genē i, is a frequent target of retroviral integration in Friend murine erythroleukemias (reviewed in Ben David and Bernstein, 1991) and is the most frequently involved ets gene in the Ewing's sarcoma translocations described above. A ubiquitously expressed member of the family, ets-2, is implicated in cell cycle control (Wen et al., 1995) . In at least one signal transduction pathway, ets-2 is linked between ras and c-myc (Langer et al., 1992) . Overexpression of ets-2 or erg in 3T3 cells results in transformation (Seth et al., 1989; Hart et al., 1995) . Thus, members of the ets family are potentially important targets in pathways leading to neoplasia.
Experimental and epidemiologic data indicates that a close relationship exists between HPV infection and genital cancer reviewed in (zuÈ r Hausen and de Villiers, 1994; DiPaolo et al., 1993) . Genital epithelial cells can be immmortalized by high risk HPV genomes, speci®cally, by the E6 and E7 genes Hawley-Nelson et al., 1989) . Many tumors have integrated HPV, with retention, and active expression of the E6/E7 region, suggesting that these genes are involved in the evolution of the tumor phenotype (Schneider-GaÈ dicke and Schwarz, 1986) . The E6 and E7 viral proteins interact with products of the tumor suppressors genes p53 and pRb, respectively (Dyson et al., 1989; Schener et al., 1990) implicating E6 and E7 in cell cycle control. HPV-immortalized cell lines can be converted to tumorigenicity by introducing activated ras (DiPaolo et al., 1989; DuÈ rst et al., 1989) . How HPV and ras cooperate in this process is unknown. However, these cell lines constitute models for studying cervical cell carcinogenesis, using etiologic factors found in naturally occurring tumors.
HPV integration sites are associated with chromosomal alterations, suggesting that HPV acts as a clastogen (Popescu and DiPaolo, 1990a; De Braekeleer et al., 1992) . Indeed, HPV integration sites commonly are associated with fragile sites and proto-oncogene loci (Popescu et al., 1990b) , suggesting that HPV integration could mediate growth selection by deregulating the expression of growth regulating host genes associated with integration sites. Previous work has shown that ets-2 is overexpressed in an HPV-16 immortalized cell line which is converted to tumorigenicity by the introduction of v-H-ras (DiPaolo et al., 1989) . In situ hybridization showed two HPV-16 integration sites on 21p and 21q22.2-22.3, the latter site near the breakpoint of a t(19;21) and the erg and ets-2 proto-oncogenes (Popescu et al., 1995) .
The current studies examine the frequency of erg and ets-2 gene activation during transformation of cervical epithelial cells and identi®es translocations encompassing the erg and ets-2 loci. Furthermore, overexpression of ets-2 in CX16-2 and the cervical carcinoma cell line C-4I was associated with sitespeci®c hypomethylation in the 5' region of ets-2. Results suggest that ets-2 is an important target for genetic changes during cervical carcinogenesis.
Results
Fragment alterations associated with the erg/ets-2 region on 21q22.2-22.3
Conventional Southern blotting analysis of cell lines (CX16-2, C-4I and C-4II) that exhibited altered expression of ets-2 or erg RNAs did not show structural changes within these genes (data not shown). To analyse potential changes in this region not seen by conventional Southern blotting, pulsed ®eld gel electrophoresis (PFGE) was undertaken (reviewed in den Dunnen and Van Ommen, 1991) . Because cytosine methylation of restriction enzyme recognition sequences prevents digestion, rare-cutting restriction enzymes are sensitive to methylation and thus can also be used to examine changes in DNA methylation (Paulien et al., 1990; Royer-Pokora and Schneider, 1992) . To identify alterations near erg or ets-2 PFGE and Southern blotting analyses were performed using probes from the region of chromosome 21 including erg and ets-2.
Comparison of normal ectocervical cells (HCX) and CX16-2, C-4I and C-4II showed multiple altered fragments in the three cell lines (Figure 1 and summarized in Table 1 ). To determine the nature of the observed altered fragments, a physical map ( Figure  2a ) of the region containing these genes was constructed using DNA fragments from (HCX); fragment data from Table 1 were integrated with cosmid and yeast arti®cial chromosome (YAC) contig map data (Chumakov et al., 1992; Ochman and Buckholtz, 1995; Patil et al., 1994) to yield the map. 3' and 5'-ets-2 probes hybridized to adjacent 640 kb and 51000 kb NruI fragments, respectively, establishing a continuous region (within the resolution of fragment measurements) of 41.5 Mbp (Table 1 , see HCX, Figure 1 ). Orientations of erg and ets-2 were derived from published data (CreÂ teÂ et al., 1993; Shimizu et al., 1993) . Physical linkage between erg and D21S55 was not established in this study; however, cosmid contig mapping places D21S55 proximal to erg, within 200 kb (Patil et al., 1994) . The above fragment data combined with published contig data supports the proposed physical map. Comparison of the hybridizing bands of the 3' erg 5' or 3'-ets-2 demonstrate that CX16-2, C-41 and C-411 have altered band sizes ( Figure 2b ).
Because CpG islands are predominantly unmethylated and inter-island rare-cutter sites are variably methylated, mapping of regional CpG islands was performed to determine the nature of putative fragment alterations. Translocation breakpoints have been associated with CpG islands (Gardiner et al., 1990) . Altered fragments associated with CpG islands would be expected to re¯ect genetic alterations (e.g., translocation) rather than variable methylation of inter-island sites.
Polymorphisms (resulting in gain or loss of restriction sites), variable methylation or genetic alterations could produce altered fragments. To investigate these possibilities, multiple samples were digested with KspI and hybridized with erg and 3'-ets-2 probes (Figure 3) . Examination of two additional ectocervical cell samples (HCX) and human sperm showed similar fragments with both probes in KspI digests ( Figure 3 , Table 2 (Gardiner et al., 1990) . However, leukocyte DNA showed multiple fragments with both probes ( Figure 3 and Table 2 ), notably a 4600 kb erg-hybridizing fragment observed in CX16-2, C-4I and C-4II and a 4400 kb 3'-ets-2-hybridizing fragment observed in C-4I. These fragments are consistent with variable methylation of inter-island KspI sites in leukocytes. These data also suggest that some of the altered fragments observed in CX16-2, C-4I and C-4II arose by altered regional methylation. Normal HCX produced predominantly larger single fragments (Figures 1 and 3 and Tables 1 and 2 ), suggesting that this region is not variably methylated in normal HCX cells. However, the smaller fragments observed in CX16-2, C-4I and C-4II are consistent with regional hypomethylation. Comparison between C-4I and C-4II erg and 5'-ets-2-hybridizing NruI fragments showed additional, altered fragments in C-4II, consistent with variable methylation of interisland NruI sites ( Figure 1 and Table 1 ). The smaller size of these fragments suggests that C-4II is hypomethylated relative to C-4I in this chromosomal region.
Other fragments observed are consistent with regional hypermethylation. Leukocytes, CX16-2, Jurkat, MOLT-3, NAB-2 and Raji exhibited erg-hybridizing fragments consistent with hypermethylation of KspI sites relative to ectocervical cells and sperm ( Figure 3 ). Partial digestion of CX16-2 showed a precursor-product relationship between the 4600 kb KspI fragment and the larger fragments, demonstrating that both hypermethylation and hypomethylation occurred in the same chromosomal region in CX16-2 ( Figure 3 ). Hypermethylation proximal to erg in CX16-2 is suggested by larger, altered D21S55-hybridizing fragments (Table 1) . Selected fragments arising from regional hypomethylation and hypermethylation are summarized in Figure 2b .
CX16-2 translocation breakpoint analysis
Previous in situ hybridization and chromosome painting studies (Popescu et al., 1995) demonstrated that an HPV-16 integration site was near the breakpoint of a t(19;21), involving 21q22.2-22.3, the erg and ets-2 loci. Physical linkage between HPV-16 and chromosome 21 was not established by PFGE (Popescu et al., 1995;  data not shown), suggesting that the integration site resides on chromosome 19 sequences in the derivative chromosome. Therefore, the distance between ets family loci in 21q22.2-22.3 and the HPV integration site could not be established without informative probes (i.e., 19q13 probes near the integration site). However, PFGE studies showed altered fragments with 21q22.2-22.3 regional probes (Figure 1 ), supporting the existence of a translocation breakpoint in the region. As the map (Figure 2b ) indicates, the 3' and 5'-ets-2 probes identify adjacent fragments with the three enzymes shown. Because adjacent BssHII fragments have CpG island termini, the altered fragments observed in CX16-2 are consistent with a translocation and not altered methylation. The occurrence of altered fragments detectable with adjacent probes suggests that changes do not result from partial digestion or altered methylation. Fusion fragments (fragments resulting from fusion of adjacent fragments) produced by either loss or methylation of a restriction site would be expected to cohybridize with probes recognizing adjacent fragments. Partial digestion studies of CX16-2 ( Figure 3 ) further suggest that altered fragments observed with ets-2 probes do not result from partial digestion or altered methylation. Because the fragments in the partial digestion are smaller than those in the complete digest, the fragments observed in the complete digest could not arise from partial digestion. Furthermore, a double-digestion with KspI + NruI and hybridization with 5'-ets-2 yielded a smear of smaller fragments compared with the KspI digest, supporting the existence of a new NruI site¯anked by KspI sites (Figure 1 , compare HCX and CX16-2). These alterations are consistent with a translocation near ets-2, juxtaposing new restriction sites from another chromosomal region with a breakpoint between 5' and 3' ets-2 probes (Figure 2 ).
C-4I and C-4II translocation breakpoint analysis
The cervical carcinoma cell lines C-4I and C-4II are clonally related yet dier karyotypically (James et al., 1989) . Interestingly, C-4I exhibits an intraline-marker chromosome described as a del (21)(q21). The presence of an altered chromosome 21 together with observed ets-2 overexpression, suggested that like CX16-2, C-4I might have a rearrangement involving the erg/ets-2 region.
Whereas analysis of ets-2-hybridizing fragments produced no evidence for genetic alterations involving ets-2 in C-4I or C-4II the erg probe showed fragment alterations consistent with a translocation distal to D21S55 and proximal to erg (Figure 1 and Table 1 ). The absence of altered D21S55-hybridizing fragments in C-4I and C-4II (Table 1) suggests that the altered 840 kb BssHII fragments in C-4I and C-4II and the 770 kb KspI fragment seen in C-4I result from a translocation and not altered methylation. Furthermore, fragments of these sizes were not observed in Figure 2 (a) Physical map of the erg/ets-2 region of human chromosome 21. A physical map encompassing the erg and ets-2 genes was constructed using normal cervical epithelial DNA digested with rare-cutting restriction enzymes that generate large fragments: B, BssHII; K, KspI; N, NruI. Fragments were separated by ®eld inversion gel electrophoresis (FIGE), transferred to nylon membranes by capillary transfer under alkaline conditions and probed with regional probes labeled by random primer labeling. Multiple blots were used to derive fragment size data. Fragment sizes varied within 10%. Fragment data was integrated with published YAC and cosmid contig map data. Probes are indicated on the map. The scale is indicated above the map at the upper left. Sizes are in kbp. Asterisks above clustered restriction sites denote putative CpG islands. Note that clustered sites are schematically represented and re¯ect limited electrophoretic resolution. The discontinuity between S55 and erg denotes a gap in the map. Normal restriction fragments are aligned and nested to show the relationships between fragments. erg and ets-2 gene orientations are derived from literature sources (see text). CEN and TEL refer to centromere and telomere, respectively. (b) Derivation of altered rare-cutter fragments seen in cell lines exhibiting altered expression of erg and ets-2. Schematic drawing showing proposed origins of selected fragments produced by altered methylation and translocations. The physical map derived from ectocervical cells is shown with inter-island KspI sites observed in leukocytes (see Table 2 (Figures 1 and 3 and Tables 1 and 2 ), suggesting that these fragments do not arise by altered methylation.
Comparison of ets-2 expression in normal ectocervical cells, ectocervical cells infected with recombinant retroviruses encoding HPV-16 E6 and E7 and cervical carcinoma cell lines
Because previous work has shown that ets-2 is overexpressed in several HPV-16 immortalized cell lines (Popescu et al., 1995) , expression was examined in several HPV-positive and two HPV-negative cervical carcinoma cells (Figure 4a and b) . Northern blot analysis demonstrated increased levels of ets-2 RNA in 6 of 10 cervical carcinoma cell lines compared to normal ectocervical cells. C-41, HeLa, QGU, QGH, SiHa and SW756 overexpressed ets-2 RNAs while CaSki, C-411, HT-3 and C-33A produced levels comparable to normal cells. Normal ectocervical cells showed low levels of ets-2 RNA. The tumor lines, produced widely dierent levels of ets-2 RNA relative to normal cells, ranging from 3.3-fold in HeLa to 10.6-fold in QGH (Figure 4a ). ets-2 expression is associated with cell proliferation (Bhat et al., 1987; 1990) suggesting that the observed dierences in expression could re¯ect variability in proliferative state. Therefore, histone H2b expression, which is maximal in S phase, was used as a control (Rickles et al., 1982) . ets-2 expression was not simply related to levels of histone H2b. For example C-41 cells expressed ets-2 RNA at a higher level than C-411 despite comparable histone H2b expression (Figure 4b) .
The low-levels of ets-2 RNA in the HPV-negative cell lines C-33A and HT-3 (Figure 4a ) raises the possibility that HPV gene products may alter ets-2 expression. However, low-level expression of ets-2 in two HPV-positive lines, C-411 ( Figure 4b ) and CaSki (Figure 4a ) suggest that ets-2 is not always activated by HPV. To directly assess whether HPV-16 E6 or E7 proteins regulate expression of ets-2 RNA normal cervical epithelial cells were infected with recombinant retroviruses encoding HPV-16 E6 and E7 genes and ets expression was measured by Northern analyses. E6 and E7 expression alone was not sucient to explain the high levels of ets-2 RNA seen in the cell lines examined (Figure 4b ) cells infected with HPV-16 E6/E7 genes expressed only slightly higher levels of ets-2 RNA than the vector-only control (Figure 4b ). Vector-only infected cells expressed lower levels of histone H2b than E6/E7 retrovirus-infected cells, consistent with their slower growth.
Altered expression of erg in CX16-2 and C-411
The ets family gene erg maps proximal to ets-2 on chromosome 21. Unlike ets-2 which is ubiquitously expressed at widely varying levels, erg expression was more limited. Northern blot analyses showed low levels of erg RNA in both normal cervical epithelial cells (HCX) and several representative cervical carcinoma cell lines ( Figure 5 ). However, CX16-2 (early and late passage) and CX16-2HR (Figure 2 ) showed a strong increase in erg RNAs (3.0 and 3.6 kb) compared to normal cervical epithelial cells and the cervical carcinoma cell lines analysed. erg expression was not simply related to proliferative state ( Figure 5 , histone H2b probe). C4-1 and C-411 displayed dierent patterns of erg expression. C4-1 produced a single erg transcript at a level comparable to normal cervical epithelial cells whereas C-411 expressed an additional 5.3 kb transcript not seen in normal cells or carcinoma cell lines.
Discussion
This study demonstrates that two transcription factors, erg and ets-2 are aberrantly expressed in a subset of HPV-immortalized and carcinoma-derived cell lines. Altered expression of erg and ets-2 in CX16-2, C-4I and C-4II may re¯ect epigenetic or genetic alterations or changes in the expression of genes controlling erg and ets-2. The t(19;21) in CX16-2, with an HPV-16 integration site near the breakpoint, involves 21q22.2-22.3, where erg and ets-2 have been mapped. ets-2 is overexpressed in CX16-2 and tumorigenic and tumor-derived cell lines derived from CX16-2. (Popescu et al., 1995) . The present study shows that ets-2 is also overexpressed in several cervical carcinoma cell lines. Although ets-2 has been associated with cell cycle progression, its expression is not simply related to proliferation or HPV expression as shown with C-33A (low ets-2 expression and high histone H2b expression in an HPV-negative cell line) or C-4II (low ets-2 expression in an HPV-positive cell line). Previous work suggests that ets-2 overexpression in D98 HeLa cell line is associated with tumorigenicity. D98/®broblast cell hybrids that reverted to tumorigenicity overexpressed ets-2 compared to non-tumorigenic hybrids (O'Hara et al., 1987) . ets family genes have been implicated in rasmediated transformation (Wasylyk et al., 1994) , suggesting that ets-2 and ras could complement. ras is frequently activated in cervical carcinomas (Riou et al., 1988) .
CX16-2, CX16-2HR and C-4II showed deregulation expression of erg transcripts, with CX16-2 and the tumorigenic CX16-2HR overexpressing erg messages and C-4II expressing a 5.3 kb transcript not seen in normal or tumorigenic cervical cells. A previous report described a minor 45 kb transcript . The absence of this transcript in the other normal and tumorigenic cells suggests that its expression could represent deregulated erg expression or alternate splicing in C-4II. The observation of two ets family genes activated in cervical carcinomas suggests, as in the case of Ewing's sarcoma, that other members of the ets family could be deregulated in cervical carcinomas.
Because altered expression is associated with chromosomal alterations in CX16-2 and C-4I, putative structural changes were examined. PFGE was used to establish the nature of potential altered fragments and a physical map spanning a 41.5 Mbp region, including erg and ets-2, was constructed using normal HCX cell DNA. Analysis of cell lines exhibiting altered expression of erg and ets-2 showed fragments not observed in normal HCX cells. Comparison of primary cells and cell lines suggests that cell lines exhibiting altered expression of erg and ets-2 had altered methylation in the chromosomal region encompassing erg and ets-2, predominantly regional hypomethylation. The previously characterized t(19;21) translocation in the CX16-2 cell line and a del(21)(q21) found in C-4I suggest that at least some of the altered fragments seen in these cell lines might result from regional translocations.
Examination of C-4I and C-4II showed that these cell lines share common altered fragments re¯ecting their clonal origin, and dierent altered fragments re¯ecting their divergent clonal evolution (see Figure  1 ). Altered expression of erg and ets-2 was associated with fragment changes produced by genetic alterations and altered regional methylation. C-4I exhibited hypomethylation of ets-2, manifested as both hypomethylation of the 5' region of ets-2 and the appearance of a smaller KspI fragment not observed in HCX or C-4II. The chromosomal segment between erg and ets-2 is apparently hypomethylated in C-4II compared with C-4I. Dierential changes in regional methylation are thus associated with clonal evolution in C-4I and C-4II, and dierential expression of erg and ets-2.
Methylation changes have been widely associated with neoplasia and tumor progression (reviewed in Baylin et al., 1991) . However, regional changes in methylation, particularly hypomethylation, associated with transcriptional changes have not been characterized. Most studies have focused on hypermethylation resulting in silencing of gene expression. Altered methylation has been associated with translocations (Paulien et al., 1990 ) and viral integration (Doer¯er, 1992) . Although the ets-2 promoter region is associated with a CpG island characteristic of housekeeping genes and thus unmethylated, the 5' region undergoes hypomethylation in cell lines exhibiting ets-2 overexpression. A HpaII/MspI methylation assay (Doer¯er, 1983) of the 5' region (data not shown) using a genomic probe obtained from the 5' region of ets-2 demonstrated that overexpression of ets-2 in C-4I and CX16-2 is associated with the appearance of a new, smaller HpaII fragment of 5.8 kb. These data suggest that overexpression in C-4I and CX16-2 is associated with site-speci®c hypomethy- Thus demethylation of a site in the 5' region of ets-2 could allow the binding of an activating factor upregulating ets-2 expression. This study suggests that regional translocations can perturb regional methylation over hundreds of kilobases. Furthermore, in the case of ets-2 overexpression in CX16-2 and C-4I, regional hypomethylation is associated with hypomethylation in the 5' region of ets-2. The 5' region of erg has not been characterized with respect to promoter elements. However, unlike ets-2, previous work (CreÂ teÂ et al., 1993) has shown that this region is not associated with a CpG island, suggesting that erg exhibits a limited, tissue-speci®c range of expression. Variable methylation observed with an erg probe (Tables 1 and 2) suggests that regional dierences in methylation could involve erg and in¯uence its transcription. The association between erg overexpression and regional hypomethylation observed in CX16-2 and possible altered transcription in C-4II suggests that erg expression could be modulated by methylation changes.
Materials and methods

Cell culture
Primary cultures of human ectocervical epithelial cells (HCX) were prepared as described (Woodworth and Simpson, 1993) . Derivation of the HPV-immortalized and ras-transformed cell lines (Woodworth et al., 1988; DiPaolo et al., 1989) and cervical carcinoma-derived cell lines C-4I, C-4II, CaSki, C-33A, HeLa, HT-3, SiHa (all from the American Type Culture Collection), QGH and QGU (Shirasawa et al., 1987) and SW756 (Freedman et al., 1982) have been described previously. Normal ectocervical cells and the cell line CX16-2 were grown in serum-free MCDB153-LB medium (Pirisi et al., 1987) . Cell lines transformed by activated c-H-ras (CX16-2HR, CX16-2HRT1) and lines derived from cervical carcinomas were grown in a 50/50 mixture of Ham's F12 nutrient medium and Dulbecco's minimal essential medium (F12/DMEM) containing hydrocortisone (0.4 mg/ml) and 5% fetal bovine serum. Actively growing, subcon¯uent cultures were used. NAB-2, a Burkitt lymphoma cell line (Gravell et al., 1976) was cultured as previously described (Popescu et al., 1990c) .
Infection of normal cells with recombinant HPV-16 E6/E7 retroviruses
Recombinant retroviruses encoding the HPV-16 E6/E7 genes have been described previously (Halbert et al., 1991) . Secondary cultures of ectocervical cells were infected with retroviral constructs consisting of the vector only or E6/E7, and cultures were subsequently selected for neomycin resistance (Woodworth et al., 1992) .
Probes and hybridizations
D21S55 (Tanzi et al., 1992) and GA5F11 (Chumakov et al., 1992) are sequence-tagged sites (STSs) de®ning unique loci, mapping to chromosome 21. D21S55 (208 bp) and GA5F11 (320 bp) PCR products were ampli®ed from placental DNA and puri®ed from gels. Other hybridization probes included: D21S3 (Watkins et al., 1985) , a 2.1 kb EcoRI fragment (clone pPW231C); erg C, a 0.95 kb EcoRI fragment derived from the 3' untranslated region of a human cDNA Reddy et al., 1987) ; 5'-ets-2, a 3.6 kb HindIII ± SstI fragment derived from the 5' promoter region of ets-2 (Mavrothalassitis et al., 1990) ; and a probe for 18S ribosomal RNA (provided by Fred Mushinski, NCI). 3'-ets-2 (H33), and histone H2b probes have been previously described (Popescu et al., 1995) . Probes were labeled by random primer labeling and hybridizations were performed as described previously (Popescu et al., 1995) . Brie¯y, blots were hybridized at 658C in 1% BSA/40 mM NaHPO 4 (pH 7.2)/1 mM EDTA/ 7% SDS and washed at 658C in 0.5% BSA/40 mM NaHPO 4 (pH 7.2)/1 mM EDTA/5% SDS followed by 40 mM NaHPO 4 (pH 7.2)/1 mM EDTA/1% SDS. The 5'-ets-2 probe was hybridized with sheared human placental DNA (Sigma, St. Louis, MO) to suppresss potential repetitive sequences (Poustka, 1990) .
Preparation of chromosomal DNA and digestion with restriction enzymes
Agarose plugs containing chromosomal DNAs (inserts) were prepared by lysis of cells embedded in low-meltingpoint agarose (Gardiner et al., 1988) . DNA inserts from sperm, leukocytes, MOLT-3 (T-cell leukemia cell line), Jurkat (T-cell leukemia cell line) and Raji (Burkitt lymphoma cell line) were prepared by standard methods (ImBed 1 kit, New England Biolabs, Beverly, MA) and were kindly donated by Zwi Berneman. DNA was digested using 20 units of restriction enzyme and 100 mg/ml BSA in the manufacturer's (New England Biolabs, Boehringer Mannheim) buer in a ®nal volume of 100 ml with overnight incubation. EDTA was added to 20 mM to stop digestions. Digested inserts were equilibrated in 16TE buer (pH 8.0) and loaded into wells either as intact blocks or pipetted into wells with wide-bore pipet tips after melting at 658C.
Field inversion gel electrophoresis
Field inversion gel electrophoresis (FIGE) was used to separate rare-cutter fragments (Carle et al., 1986) . Digested DNA was separated on 1% GTG agarose (FMC BioProducts, Rockland, ME) gels run in an HE100 horizontal gel apparatus (Hoefer Scienti®c, San Francisco, CA) cooled with circulating water at 88C, using 0.56TBE buer and an applied voltage of 200 V. Switching was performed using a PPI-200 v200.20 programmable electrophoresis controller and Program 7 (MJ Research, Inc., Watertown, MA). Fragment sizes were determined using yeast chromosomes (YPH 80) and lambda concatemers (c/857 ind1 Sam7) from New England Biolabs (Beverly, MA) as size standards.
Southern blotting
FIGE gels were depurinated by two successive treatments in 0.25 N HCl for 10 min each, followed by two 15 min treatments in 0.5 mM NaOH ± 1.5 M NaCl. DNA fragments were transferred to Gene Screen Plus (DuPont/NEN) membranes by capillary transfer using 0.5 M NaOH ± 1.5 M NaCl (Sambrook et al., 1989) .
DNA used for conventional Southern blots was prepared by standard methods (Sambrook et al., 1989) or DNA inserts were melted at 658C and used in restriction enzyme digestions. Restriction enzyme digestions were performed using manufacturer's (Promega, New England Biolabs, Boehringer Mannheim) buers. DNA was separated in agarose gels by standard methods and gels were prepared for DNA transfer as above except following the 0.5 M NaOH ± 1.5 M NaCl treatment, gels were neutralized with 1 M Tris-HCl (pH 7.5) ± 1.5 M NaCl using two 15 min washes and DNA was transferred to Gene Screen Plus or Nytran membranes by capillary transfer with 106SSC. DNA was ®xed to membranes by u.v.-crosslinking, using 120 000 mJ/cm 2 (Stratalinker, Stratagene, La Jolla, CA).
Northern blotting
RNA was isolated and separated on 1% agaroseformaldehyde gels as described previously (Popescu et al., 1995) and transferred to Nytran membranes under alkaline conditions by upward capillary transfer using 3 M NaCl-8 mM NaOH-2 mM Sarkosyl (Chomczynski, 1992) . Densitometric analyses were performed by scanning X-ray ®lms using a Hewlett Packard Desk Scan II and uncalibrated optial density (OD) units were calculated using NIH Image v. 1.55 software (Wayne Rasband, National Institute of Health, Bethesda, MD).
